pyrazines has been researched along with Conus Medullaris Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K | 1 |
| Cheong, YJ; Kang, C; Moon, JY; Seong, JW; Shin, JW; Sohn, NW; Song, SH | 1 |
| Zhang, J; Zhong, Y | 1 |
| Cavero, S; Español, I; Funes, C; García, MC; Ibáñez, J; Iturbe, T; López, MD; Martínez, A; Tejedor, A | 1 |
| Birraux, G; Bohme, GA; Boireau, A; Damour, D; Debono, MW; Genevois-Borella, A; Jimonet, P; Mignani, S; Pratt, J; Stutzmann, JM; Vuilhorgne, M; Wahl, F | 1 |
5 other study(ies) available for pyrazines and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Myeloma presenting during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous | 2014 |
Effects of tetramethylpyrazine on microglia activation in spinal cord compression injury of mice.
Topics: Animals; Cyclooxygenase 2; Drugs, Chinese Herbal; Inflammation Mediators; Interleukin-1beta; Ligusticum; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Phytotherapy; Pyrazines; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries; Tumor Necrosis Factor-alpha; Up-Regulation | 2013 |
Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Boronic Acids; Bortezomib; Combined Modality Therapy; Decompression, Surgical; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Invasiveness; Prognosis; Pyrazines; Retrospective Studies; Spinal Canal; Spinal Cord Compression; Treatment Outcome | 2015 |
First report of a medullar cord compression secondary to osseous plasmacytoma successfully treated with bortezomib and dexamethasone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Boronic Acids; Bortezomib; Dexamethasone; Female; Humans; Middle Aged; Plasmacytoma; Pyrazines; Spinal Cord Compression; Treatment Outcome | 2010 |
9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic acid (RPR117824): selective anticonvulsive and neuroprotective AMPA antagonist.
Topics: Animals; Anticonvulsants; Brain Injuries; Brain Ischemia; Disease Models, Animal; Gerbillinae; Imidazoles; Male; Neuroprotective Agents; Oocytes; Protein Binding; Pyrazines; Radioligand Assay; Rats; Receptors, AMPA; Reperfusion Injury; Seizures; Spinal Cord Compression; Synapses; Xenopus | 2002 |